Evidence map›Paper›PMID 34135355›Full record

ArticleScientific reports2021

AMRFinderPlus and the Reference Gene Catalog facilitate examination of the genomic links among antimicrobial resistance, stress response, and virulence.

Michael Feldgarden, Vyacheslav Brover, Narjol Gonzalez-Escalona, Jonathan G Frye, Julie Haendiges, Daniel H Haft, Maria Hoffmann, James B Pettengill, Arjun B Prasad, Glenn E Tillman and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1,101 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,101citing papers in PubMed, 1 pooled it
56.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1,101 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,401 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Genomic and phenotypic insight intoEmerging microbes & infections · 2026
    Article
  7. Emergence of carbapenem-resistant putative hypervirulentEmerging microbes & infections · 2026
    Article
  8. Azithromycin-resistantJAC-antimicrobial resistance · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Antibiotics (Basel, Switzerland) · 2026
    Article
  15. The Oxytetracycline ProducerInternational journal of molecular sciences · 2026
    Article
  16. Article
  17. Article
  18. Review
  19. Draft genome sequence ofMicrobiology resource announcements · 2026
    Article
  20. Draft genome sequence ofMicrobiology resource announcements · 2026
    Article

1,041 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Michael FeldgardenNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA. michael.feldgarden@nih.gov.
Vyacheslav BroverNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Narjol Gonzalez-EscalonaCenter for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
Jonathan G FryeBacterial Epidemiology and Antimicrobial Resistance Research Unit, U.S. National Poultry Research Center, Agricultural Research Service, U.S. Department of Agriculture, Athens, GA, USA.
Julie HaendigesCenter for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
Daniel H HaftNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Maria HoffmannCenter for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
James B PettengillCenter for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, College Park, Maryland, USA.
Arjun B PrasadNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
Glenn E TillmanFood Safety and Inspection Service, U.S. Department of Agriculture, Athens, GA, USA.
Gregory H TysonCenter for Veterinary Medicine, U.S. Food and Drug Administration, Laurel, MD, USA.
William KlimkeNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA.
National Institutes of Health · USUnited States Food and Drug Administration · USCenter for Food Safety and Applied Nutrition · USNational Center for Biotechnology Information · USFood Safety and Inspection Service · USU.S. National Poultry Research Center · US

Funding

National Biomedical Information ServicesZIHLM200888 · NLM · NATIONAL LIBRARY OF MEDICINE · PI PALTOO, DINA · 2009 to 2025
$5200.7M
6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a significant public health threat. With the rise of affordable whole genome sequencing, in silico approaches to assessing AMR gene content can be used to detect known resistance mechanisms and potentially identify novel mechanisms. To enable accurate assessment of AMR gene content, as part of a multi-agency collaboration, NCBI developed a comprehensive AMR gene database, the Bacterial Antimicrobial Resistance Reference Gene Database and the AMR gene detection tool AMRFinder. Here, we describe the expansion of the Reference Gene Database, now called the Reference Gene Catalog, to include putative acid, biocide, metal, stress resistance genes, in addition to virulence genes and species-specific point mutations. Genes and point mutations are classified by broad functions, as well as more detailed functions. As we have expanded both the functional repertoire of identified genes and functionality, NCBI released a new version of AMRFinder, known as AMRFinderPlus. This new tool allows users the option to utilize only the core set of AMR elements, or include stress response and virulence genes, too. AMRFinderPlus can detect acquired genes and point mutations in both protein and nucleotide sequence. In addition, the evidence used to identify the gene has been expanded to include whether nucleotide or protein sequence was used, its location in the contig, and presence of an internal stop codon. These database improvements and functional expansions will enable increased precision in identifying AMR genes, linking AMR genotypes and phenotypes, and determining possible relationships between AMR, virulence, and stress response.

Indexed as

Databases, GeneticGenes, BacterialAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialDrug Resistance, Multiple, BacterialGenome, BacterialMercuryPlasmidsSalmonellaVirulenceAnti-Bacterial AgentsMercury

Identifiers

PMID34135355
PMCPMC8208984
OpenAlexW3170689505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.